Display options
Cite
Albala MM, Davignon D, Fast LD, et al. Normal T cell subsets and lymphocyte activity in multiple sclerosis. Clin Exp Immunol. 1985;61(3):542-7
Albala, M. M., Davignon, D., Fast, L. D., & Clark, D. D. (1985). Normal T cell subsets and lymphocyte activity in multiple sclerosis. Clinical and experimental immunology, 61(3), 542-7.
Albala, M M, et al. "Normal T cell subsets and lymphocyte activity in multiple sclerosis." Clinical and experimental immunology vol. 61,3 (1985): 542-7.
Albala MM, Davignon D, Fast LD, Clark DD. Normal T cell subsets and lymphocyte activity in multiple sclerosis. Clin Exp Immunol. 1985 Sep;61(3):542-7. PMID: 3878242; PMCID: PMC1577277.
Copy Download .nbib Format: NLM
Share it on

Clin Exp Immunol. 1985 Sep;61(3):542-7.

Normal T cell subsets and lymphocyte activity in multiple sclerosis.

Clinical and experimental immunology

M M Albala, D Davignon, L D Fast, D D Clark

PMID: 3878242 PMCID: PMC1577277

Abstract

Nine patients with either chronic progressive or relapsing/remitting multiple sclerosis were treated with several courses of lymphopheresis. The lymphocytes obtained by this procedure showed a significantly lower percentage of OKT3+ cells than normal controls at the beginning of therapy. This percentage increased to normal levels after five lymphopheresis treatments and then decreased during the last stages of treatment. Patients had normal levels of OKT4+ and OKT8+ cells compared to controls and these percentages showed no statistically significant changes during the course of treatment. The proliferative response of patient's lymphocytes after stimulation with concanavalin A, PHA and alloantigen was not significantly different from normal controls and these responses were unchanged during the lymphopheresis treatment. Natural killer cell activity was also normal in our patients. The results reported in this study do not suggest a basic T cell abnormality in our patients with multiple sclerosis. Furthermore, the lymphopheresis treatments did not induce any significant change in T cell numbers or functional activity in vitro.

References

  1. J Immunol. 1974 Dec;113(6):2035-9 - PubMed
  2. Ann Neurol. 1983 Nov;14(5):593-4 - PubMed
  3. N Engl J Med. 1977 Dec 1;297(22):1207-11 - PubMed
  4. Ann Neurol. 1979 Apr;5(4):338-42 - PubMed
  5. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4061-5 - PubMed
  6. J Immunol. 1980 Mar;124(3):1301-7 - PubMed
  7. Clin Exp Immunol. 1980 Mar;39(3):657-62 - PubMed
  8. N Engl J Med. 1980 Jul 17;303(3):125-9 - PubMed
  9. Nature. 1980 Sep 25;287(5780):335-7 - PubMed
  10. Lancet. 1980 Dec 6;2(8206):1221-3 - PubMed
  11. J Immunol. 1981 Apr;126(4):1274-8 - PubMed
  12. Blood. 1981 Sep;58(3):451-8 - PubMed
  13. Vox Sang. 1981 Nov-Dec;41(5-6):287-94 - PubMed
  14. Immunobiology. 1982 Feb;160(5):392-402 - PubMed
  15. Clin Exp Immunol. 1982 Feb;47(2):419-30 - PubMed
  16. Proc Natl Acad Sci U S A. 1982 May;79(10):3330-4 - PubMed
  17. Ann Neurol. 1982 May;11(5):456-62 - PubMed
  18. Ann Neurol. 1983 Apr;13(4):418-25 - PubMed
  19. J Neurol Neurosurg Psychiatry. 1983 Feb;46(2):105-14 - PubMed
  20. Clin Exp Immunol. 1983 Jul;53(1):133-9 - PubMed
  21. J Neuroimmunol. 1983 Aug;5(1):67-81 - PubMed
  22. J Neurol Sci. 1983 Jul;60(1):137-50 - PubMed
  23. Ann Neurol. 1983 Sep;14(3):333-8 - PubMed
  24. Ann Neurol. 1983 Oct;14(4):445-9 - PubMed
  25. Clin Immunol Immunopathol. 1977 Jan;7(1):15-23 - PubMed

MeSH terms

Publication Types

LinkOut - more resources